Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development

Arie Regev, Mark I. Avigan, Alexandre Kiazand, John M. Vierling, James H. Lewis, Stephanie O. Omokaro, Adrian M. Di Bisceglie, Robert J. Fontana, Herbert L. Bonkovsky, James W. Freston, Jack P. Uetrecht, Ethan D. Miller, Nonko D. Pehlivanov, Syed Asif Haque, Melanie J. Harrison, Gerd A. Kullak-Ublick, Hewei Li, Niti N. Patel, Meenal Patwardhan, Karen D. PricePaul B. Watkins, Naga P. Chalasani

Research output: Contribution to journalReview article

Fingerprint Dive into the research topics of 'Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development'. Together they form a unique fingerprint.

Medicine & Life Sciences